Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group
HTS Benamer, J Patterson, DG Grosset… - … : official journal of the …, 2000 - Wiley Online Library
OBJECTIVE: To evaluate whether visual assessment of [123I]-FP-CIT (DaTSCAN™, Nycomed
Amersham, plc) single photon emission computerized tomography (SPECT) images can …
Amersham, plc) single photon emission computerized tomography (SPECT) images can …
[PDF][PDF] Consensus on microembolus detection by TCD
…, DW Droste, VL Babikian, DH Evans, DG Grosset… - Stroke, 1998 - academia.edu
Transcranial Doppler ultrasound is capable of detecting microembolic material, both gaseous
and solid, within the intracranial cerebral arteries. To avoid discrediting this promising and …
and solid, within the intracranial cerebral arteries. To avoid discrediting this promising and …
Correlation of Parkinson's disease severity and duration with 123I‐FP‐CIT SPECT striatal uptake
…, DM Hadley, GJA Macphee, DG Grosset - … : official journal of the …, 2000 - Wiley Online Library
The variability in clinical features and the masking effects of drug therapy in Parkinson's
disease (PD) can affect clinical assessment of disease severity. The aim of this study was to …
disease (PD) can affect clinical assessment of disease severity. The aim of this study was to …
Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT
…, H Höffken, A Gerstner, DG Grosset - Movement …, 2009 - Wiley Online Library
Overdiagnosis of Parkinson's disease (PD) is suggested by specialist review of community
diagnosis, and in postmortem studies. In specialist centers 4 to 15% of patients entered into …
diagnosis, and in postmortem studies. In specialist centers 4 to 15% of patients entered into …
Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms
…, P Tienari, K Majamaa, M Toft, DG Grosset… - Movement …, 2019 - Wiley Online Library
Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …
Suboptimal medication adherence in Parkinson's disease
KA Grosset, I Bone, DG Grosset - Movement disorders: official …, 2005 - Wiley Online Library
Patients take less medication than prescribed in many disease areas but evidence for
suboptimal therapy adherence in Parkinson's disease (PD) is limited. A single‐center …
suboptimal therapy adherence in Parkinson's disease (PD) is limited. A single‐center …
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study
…, M Dujardin, DG Grosset, G Arnold… - Movement …, 2006 - Wiley Online Library
Dopamine agonists are used as initial treatment in patients with Parkinson's disease (PD) to
reduce incidence and severity of motor complications. This paradigm is based on long‐term …
reduce incidence and severity of motor complications. This paradigm is based on long‐term …
Genome‐wide association studies of cognitive and motor progression in Parkinson's disease
…, L Hubbard, N Malek, KA Grosset… - Movement …, 2021 - Wiley Online Library
Background There are currently no treatments that stop or slow the progression of Parkinson's
disease (PD). Case–control genome‐wide association studies have identified variants …
disease (PD). Case–control genome‐wide association studies have identified variants …
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
…, MA Lawton, DMA Swallow, KA Grosset… - Movement …, 2016 - Wiley Online Library
Objective The purpose of this study was to examine the relationship between vascular disease
(and vascular risk factors), cognition and motor phenotype in Parkinson's disease (PD). …
(and vascular risk factors), cognition and motor phenotype in Parkinson's disease (PD). …
Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3‐month observations
…, H Höffken, A Gerstner, DG Grosset - … : official journal of the …, 2003 - Wiley Online Library
To record prospectively, from early presentation, the clinical features of parkinsonism and
tremor disorders, in relation to evidence of dopaminergic deficit shown with [ 123 I]‐FP‐CIT (…
tremor disorders, in relation to evidence of dopaminergic deficit shown with [ 123 I]‐FP‐CIT (…